메뉴 건너뛰기




Volumn 13, Issue 3, 2008, Pages 167-170

Drug-induced burning mouth syndrome: A new etiological diagnosis

Author keywords

Angiotensin II receptor antagonists; Angiotensin converting enzyme inhibitors; Antihypertensive drugs; Burning mouth syndrome; Drug induced

Indexed keywords

CANDESARTAN; CAPTOPRIL; CLONAZEPAM; EFAVIRENZ; ENALAPRIL; EPROSARTAN; FLUOXETINE; LISINOPRIL; SERTRALINE; VENLAFAXINE;

EID: 41849101068     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (49)

References (35)
  • 1
    • 27944477358 scopus 로고    scopus 로고
    • Burning mouth syndrome: Concepts review and update
    • Jan;
    • Silvestre FJ, Serrano C. Burning mouth syndrome: concepts review and update. Med Oral. 1997 Jan;2(1):30-8.
    • (1997) Med Oral , vol.2 , Issue.1 , pp. 30-38
    • Silvestre, F.J.1    Serrano, C.2
  • 2
    • 0029420560 scopus 로고
    • General health factors and denture function in patients with burning mouth syndrome and matched control subjects
    • Dec;
    • Svensson P, Kaaber S. General health factors and denture function in patients with burning mouth syndrome and matched control subjects. J Oral Rehabil. 1995 Dec;22(12):887-95.
    • (1995) J Oral Rehabil , vol.22 , Issue.12 , pp. 887-895
    • Svensson, P.1    Kaaber, S.2
  • 3
    • 0033198774 scopus 로고    scopus 로고
    • Burning mouth syndrome: Prevalence and associated factors
    • Sep;
    • Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med. 1999 Sep;28(8):350-4.
    • (1999) J Oral Pathol Med , vol.28 , Issue.8 , pp. 350-354
    • Bergdahl, M.1    Bergdahl, J.2
  • 4
    • 0033126562 scopus 로고    scopus 로고
    • Referral patterns, lesion prevalence, and patient care parameters in a clinical oral pathology practice
    • May;
    • Haberland CM, Allen CM, Beck FM. Referral patterns, lesion prevalence, and patient care parameters in a clinical oral pathology practice. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 May;87(5):583-8.
    • (1999) Oral Surg Oral Med Oral Pathol Oral Radiol Endod , vol.87 , Issue.5 , pp. 583-588
    • Haberland, C.M.1    Allen, C.M.2    Beck, F.M.3
  • 8
    • 0034917271 scopus 로고    scopus 로고
    • Burning mouth syndrome after taking clonazepam
    • Jul-Aug;
    • Culhane NS, Hodle AD. Burning mouth syndrome after taking clonazepam. Ann Pharmacother. 2001 Jul-Aug;35(7-8):874-6.
    • (2001) Ann Pharmacother , vol.35 , Issue.7-8 , pp. 874-876
    • Culhane, N.S.1    Hodle, A.D.2
  • 9
    • 0032149383 scopus 로고    scopus 로고
    • A possible therapeutic solution for stomatodynia (burning mouth syndrome)
    • Fall;
    • Woda A, Navez ML, Picard P, Gremeau C, Pichard-Leandri E. A possible therapeutic solution for stomatodynia (burning mouth syndrome). J Orofac Pain. 1998 Fall;12(4):272-8.
    • (1998) J Orofac Pain , vol.12 , Issue.4 , pp. 272-278
    • Woda, A.1    Navez, M.L.2    Picard, P.3    Gremeau, C.4    Pichard-Leandri, E.5
  • 10
    • 10744233923 scopus 로고    scopus 로고
    • Topical clonazepam in stomatodynia: A randomised placebo-controlled study
    • Mar;
    • Gremeau-Richard C, Woda A, Navez ML, Attal N, Bouhassira D, Gagnieu MC, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain. 2004 Mar;108(1-2):51-7.
    • (2004) Pain , vol.108 , Issue.1-2 , pp. 51-57
    • Gremeau-Richard, C.1    Woda, A.2    Navez, M.L.3    Attal, N.4    Bouhassira, D.5    Gagnieu, M.C.6
  • 12
    • 20144371735 scopus 로고    scopus 로고
    • A burning mouth associated with the use of hormone replacement therapy
    • Mar;
    • Palin SL, Kumar S, Barnett AH, Sturdee DW. A burning mouth associated with the use of hormone replacement therapy. J Br Menopause Soc. 2005 Mar;11(1):38.
    • (2005) J Br Menopause Soc , vol.11 , Issue.1 , pp. 38
    • Palin, S.L.1    Kumar, S.2    Barnett, A.H.3    Sturdee, D.W.4
  • 13
    • 85043696043 scopus 로고    scopus 로고
    • Burning mouth syndrome as a side effect of SSRIs
    • Mar;
    • Levenson JL. Burning mouth syndrome as a side effect of SSRIs. J Clin Psychiatry. 2003 Mar;64(3):336-7.
    • (2003) J Clin Psychiatry , vol.64 , Issue.3 , pp. 336-337
    • Levenson, J.L.1
  • 14
    • 3042701589 scopus 로고    scopus 로고
    • Stomatodynia (burning mouth) as a complication of enalapril therapy
    • Jul;
    • Triantos D, Kanakis P. Stomatodynia (burning mouth) as a complication of enalapril therapy. Oral Dis. 2004 Jul;10(4):244-5.
    • (2004) Oral Dis , vol.10 , Issue.4 , pp. 244-245
    • Triantos, D.1    Kanakis, P.2
  • 16
    • 0037202703 scopus 로고    scopus 로고
    • Drug points: Dysgeusia and burning mouth syndrome by eprosartan
    • Nov 30;
    • Castells X, Rodoreda I, Pedros C, Cereza G, Laporte JR. Drug points: Dysgeusia and burning mouth syndrome by eprosartan. BMJ. 2002 Nov 30;325(7375):1277.
    • (2002) BMJ , vol.325 , Issue.7375 , pp. 1277
    • Castells, X.1    Rodoreda, I.2    Pedros, C.3    Cereza, G.4    Laporte, J.R.5
  • 18
    • 0026480534 scopus 로고
    • Lisinopril-induced "scalded mouth syndrome
    • Nov;
    • Savino LB, Haushalter NM. Lisinopril-induced "scalded mouth syndrome". Ann Pharmacother. 1992 Nov;26(11):1381-2.
    • (1992) Ann Pharmacother , vol.26 , Issue.11 , pp. 1381-1382
    • Savino, L.B.1    Haushalter, N.M.2
  • 20
    • 0027471485 scopus 로고
    • Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales
    • Mar;
    • Rojo L, Silvestre FJ, Bagan JV, De Vicente T. Psychiatric morbidity in burning mouth syndrome. Psychiatric interview versus depression and anxiety scales. Oral Surg Oral Med Oral Pathol. 1993 Mar;75(3):308-11.
    • (1993) Oral Surg Oral Med Oral Pathol , vol.75 , Issue.3 , pp. 308-311
    • Rojo, L.1    Silvestre, F.J.2    Bagan, J.V.3    De Vicente, T.4
  • 21
    • 0028503709 scopus 로고
    • Prevalence of psychopathology in burning mouth syndrome. A comparative study among patients with and without psychiatric disorders and controls
    • Sep;
    • Rojo L, Silvestre FJ, Bagan JV, De Vicente T. Prevalence of psychopathology in burning mouth syndrome. A comparative study among patients with and without psychiatric disorders and controls. Oral Surg Oral Med Oral Pathol. 1994 Sep;78(3):312-6.
    • (1994) Oral Surg Oral Med Oral Pathol , vol.78 , Issue.3 , pp. 312-316
    • Rojo, L.1    Silvestre, F.J.2    Bagan, J.V.3    De Vicente, T.4
  • 22
    • 0027679435 scopus 로고
    • Estimated prevalence and distribution of reported orofacial pain in the United States
    • Oct;
    • Lipton JA, Ship JA, Larach-Robinson D. Estimated prevalence and distribution of reported orofacial pain in the United States. J Am Dent Assoc. 1993 Oct; 124(10):115-21.
    • (1993) J Am Dent Assoc , vol.124 , Issue.10 , pp. 115-121
    • Lipton, J.A.1    Ship, J.A.2    Larach-Robinson, D.3
  • 23
    • 0031299385 scopus 로고    scopus 로고
    • Reported burning mouth symptoms among middle-aged and elderly women
    • Dec;
    • Hakeberg M, Berggren U, Hägglin C, Ahlqwist M. Reported burning mouth symptoms among middle-aged and elderly women. Eur J Oral Sci. 1997 Dec;105(6):539-43.
    • (1997) Eur J Oral Sci , vol.105 , Issue.6 , pp. 539-543
    • Hakeberg, M.1    Berggren, U.2    Hägglin, C.3    Ahlqwist, M.4
  • 25
    • 23644456958 scopus 로고    scopus 로고
    • Soares MS, Chimenos-Küstner E, Subirá-Pifarrè C, Rodríguez de Rivera-Campillo ME, López-López J. Association of burning mouth syndrome with xerostomia and medicines. Med Oral Patol Oral Cir Bucal. 2005 Aug-Oct;10(4):301-8.
    • Soares MS, Chimenos-Küstner E, Subirá-Pifarrè C, Rodríguez de Rivera-Campillo ME, López-López J. Association of burning mouth syndrome with xerostomia and medicines. Med Oral Patol Oral Cir Bucal. 2005 Aug-Oct;10(4):301-8.
  • 26
    • 41849093291 scopus 로고    scopus 로고
    • Fármacos antihipertensivos
    • Flórez J, Armijo JA, Mediavilla A eds.3 a ed. Barcelona: Masson;
    • a ed. Barcelona: Masson; 1997. p. 671-83.
    • (1997) Farmacología humana , pp. 671-683
    • Galiana, J.1    Gil, M.2
  • 27
    • 0032906908 scopus 로고    scopus 로고
    • Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: Results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group
    • Gavras I, Gavras H. Effects of eprosartan versus enalapril in hypertensive patients on the renin-angiotensin-aldosterone system and safety parameters: results from a 26-week, double-blind, multicentre study. Eprosartan Multinational Study Group. Curr Med Res Opin. 1999;15(1):15-24.
    • (1999) Curr Med Res Opin , vol.15 , Issue.1 , pp. 15-24
    • Gavras, I.1    Gavras, H.2
  • 28
    • 0035210938 scopus 로고    scopus 로고
    • Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients
    • Nov;
    • Ichikawa S, Takayama Y. Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients. Hypertens Res. 2001 Nov;24(6):641-6.
    • (2001) Hypertens Res , vol.24 , Issue.6 , pp. 641-646
    • Ichikawa, S.1    Takayama, Y.2
  • 29
    • 0028962451 scopus 로고
    • The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension
    • Apr;
    • Burris JF. The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension. J Clin Pharmacol. 1995 Apr;35(4):337-42.
    • (1995) J Clin Pharmacol , vol.35 , Issue.4 , pp. 337-342
    • Burris, J.F.1
  • 31
    • 33846241330 scopus 로고    scopus 로고
    • Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: Evidence for ACE2-dependent processing of angiotensin II
    • Jan;
    • Shaltout HA, Westwood BM, Averill DB, Ferrario CM, Figueroa JP, Diz DI, et al. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am J Physiol Renal Physiol. 2007 Jan;292(1):F82-91.
    • (2007) Am J Physiol Renal Physiol , vol.292 , Issue.1
    • Shaltout, H.A.1    Westwood, B.M.2    Averill, D.B.3    Ferrario, C.M.4    Figueroa, J.P.5    Diz, D.I.6
  • 33
    • 0034028647 scopus 로고    scopus 로고
    • Angiotensine-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man
    • Apr;
    • Ueda S, Masumori-Maemoto S, Ashino K, Nagahara T, Gotoh E, Umemura S, et al. Angiotensine-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. Hypertension. 2000 Apr;35(4):998-1001.
    • (2000) Hypertension , vol.35 , Issue.4 , pp. 998-1001
    • Ueda, S.1    Masumori-Maemoto, S.2    Ashino, K.3    Nagahara, T.4    Gotoh, E.5    Umemura, S.6
  • 34
    • 2342620869 scopus 로고    scopus 로고
    • Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors
    • May;
    • Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM. Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension. 2004 May;43(5):970-6.
    • (2004) Hypertension , vol.43 , Issue.5 , pp. 970-976
    • Ishiyama, Y.1    Gallagher, P.E.2    Averill, D.B.3    Tallant, E.A.4    Brosnihan, K.B.5    Ferrario, C.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.